Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2015-10-23 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Resultat for 3. kvartal 2015 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Medistim for the third quarter of 2015. It contains detailed financial statements, including income statements, balance sheet data, operational status by region, clinical study updates, and management's analysis of financial performance (EBIT, EBITDA, revenue growth, etc.). It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year. Q3 2015
2015-10-23 Norwegian
Resultat for 3. kvartal 2015 for Medistim ASA
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Third Quarter 2015" and contains detailed financial tables for Q3 2015 and Year-to-Date (YTD) September 2015, including Profit and Loss statements, Balance Sheets, and segment performance analysis. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year. The presence of detailed financial statements and management commentary strongly suggests an Interim/Quarterly Report, which corresponds to the 'IR' filing type code. It is not an Earnings Release (ER) because it contains full financial statements, not just highlights, and it is not a 10-K as it covers only the third quarter.
2015-10-23 Norwegian
Resultat for 3. kvartal 2015 for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly states 'Resultat for 3. kvartal 2015 for Medistim ASA' and provides key financial metrics (revenue, EBIT, EPS) for the third quarter and year-to-date figures. This content structure, focusing on period-specific financial highlights, strongly indicates an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since the text provides the core financial results summary (highlights) rather than the comprehensive, detailed report often associated with an IR, and given its brevity (918 chars), it aligns best with an Earnings Release (ER) which is the initial announcement of periodical financial results. Q3 2015
2015-10-23 Norwegian
Medistim ASA enters into a strategic partnership with em-tec GmbH
Regulatory Filings Classification · 95% confidence The document announces a strategic partnership, specifically a License and OEM agreement, between Medistim ASA and em-tec GmbH concerning technology rights and future product development. This type of announcement details a significant business transaction that affects the company's structure and future operations, but it is not a standard financial report (like 10-K, IR, ER) or a management/board change (MANG). It is a material event announcement. Since there is no specific category for 'Strategic Partnership' or 'Material Business Event', and it does not fit clearly into financing (CAP), M&A (TAR), or insider trading (DIRS), the most appropriate general category for significant, non-standard corporate news that requires immediate disclosure is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous regulatory announcements, especially given the closing line referencing disclosure under Norwegian law (§5-12).
2015-10-22 English
Medistim ASA inngår strategisk samarbeid med em-tec GmbH
Regulatory Filings Classification · 100% confidence The document announces a strategic collaboration, specifically a license and OEM agreement between Medistim ASA and em-tec GmbH regarding technology for blood flow measurement. This type of announcement, detailing a significant business transaction (partnership, licensing, or M&A activity), is typically classified as a general regulatory announcement or a specific transaction report. Since there is no specific code for 'Strategic Partnership Announcement' and the content is a formal press release detailing a business development that impacts the company's operations and future product line, it fits best under a general regulatory filing or a transaction-related category. Given the options, this is a material event announcement. It is not an Earnings Release (ER), Interim Report (IR), or a formal M&A filing (TAR), but rather a significant business development announcement. In many databases, such material business updates that aren't explicitly financial reports or insider trades fall under general regulatory filings (RNS) or sometimes M&A/Transaction (TAR) if it involves acquiring rights. Since this is a licensing/OEM deal, it is a material business event. Given the available codes, RNS (Regulatory Filings - general fallback) is appropriate, although TAR (M&A Activity) might be considered if the rights acquisition is substantial. However, RNS is the safest general category for non-standard material announcements not covered elsewhere. The document length (3668 chars) is short, but it is the primary announcement, not an announcement *of* another report, so RPA is incorrect. I will classify it as RNS as it is a general regulatory disclosure of a material event.
2015-10-22 Norwegian
Presentation of third quarter results for 2015 for Medistim ASA
Investor Presentation Classification · 95% confidence The document text is very short (495 characters) and explicitly states it is an invitation to a 'Presentation of third quarter results for 2015'. It details the time, date, and location for this presentation, featuring the CEO and CFO. This structure strongly suggests an announcement about an upcoming event where results will be discussed, rather than the full results document itself (like an IR or ER). Since it is an announcement related to financial results presentation, it aligns best with an Investor Presentation (IP) or potentially an Earnings Release (ER) announcement, but given the context of inviting people to a presentation event, Investor Presentation (IP) is the most fitting category for the material being presented, or if it were just the announcement of the presentation event itself, it could lean towards RPA or RNS. However, since the content is about the presentation of quarterly results, and it's an invitation, it is most closely related to the material that will be presented, which is an Investor Presentation (IP). If the document were the actual results, it would be IR or ER. Given the invitation format, IP is the best fit for the subject matter being presented.
2015-10-16 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.